Susquehanna International Group’s Rennova Health, Inc. RNVA Stock Holding History

Susquehanna International Group’s Portfolio RNVA Stock Details RNVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-124	Closed	-$5K	–	10700
2016 Q4	$5K	Buy	+124	New	+$7.04K	﹤0.01%	9489
2015 Q3	–	Sell	-18	Closed	-$56K	–	10640
2015 Q2	$56K	Buy	+18	New	+$67.6K	﹤0.01%	9853

Other funds holding RNVA

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Susquehanna International Group's RNVA Position: Q1 2017 in Review

Susquehanna International Group sold out of Rennova Health, Inc. (RNVA) in Q1 2017, closing a stake of 124 shares — an estimated $5K sold.

Susquehanna International Group first reported a position in RNVA in Q2 2015 and held it in 2 quarters. The position peaked at $56K in Q2 2015. 9 funds tracked by Wall St. Rank hold RNVA as of Q1 2017.

Susquehanna International Group reported no remaining Rennova Health, Inc. position as of Q1 2017 after selling out during the quarter.
Susquehanna International Group sold 124 Rennova Health, Inc. shares in Q1 2017, an estimated $5K.
Susquehanna International Group first reported a position in Rennova Health, Inc. in Q2 2015 and held it in 2 quarters.
Susquehanna International Group's Rennova Health, Inc. position peaked at $56K in Q2 2015.
9 funds tracked by Wall St. Rank held Rennova Health, Inc. as of Q1 2017.

Based on Susquehanna International Group's 13F filing for Q1 2017, filed 15 May 2017.